Rilapladib

CAS No.

412950-08-4

MDL No.

MFCD13195581

C₄₀H₃₈F₅N₃O₃S

735.80

InChI Key

NNBGCSGCRSCFEA-UHFFFAOYSA-N

Pack Size	Purity	Price	Availability
1 mg	98%	$212	In Stock
5 mg	98%	$533	In Stock
10 mg	98%	$845	In Stock
25 mg	98%	$1332	In Stock
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

1 mg

98%

$212

In Stock

5 mg

98%

$533

In Stock

10 mg

98%

$845

In Stock

25 mg

98%

$1332

In Stock

Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	412950-08-4
Product Name	Rilapladib

Biological Targets

PLA2G7

Associated Conditions

Alzheimer disease·atherosclerosis

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Documentation

Rilapladib

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Related Articles

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Darapladib, a lipoprotein-associated phospholipase A2 inhibitor, in diabetic macular edema: a 3-month placebo-controlled study.

Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study.

Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study.

Documentation